IBDEI1Z9 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1111,0)
 ;;=BRAIN DISORDERS^6^104
 ;;^UTILITY(U,$J,358.4,1112,0)
 ;;=PSYCHOTHERAPY (INPT OR OUTPT)^6^105
 ;;^UTILITY(U,$J,358.4,1113,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^7^105
 ;;^UTILITY(U,$J,358.4,1114,0)
 ;;=OTHER CODES^3^105
 ;;^UTILITY(U,$J,358.4,1115,0)
 ;;=BEHAVIOR ASSESSMENT/INTERVENTION^1^105
 ;;^UTILITY(U,$J,358.4,1116,0)
 ;;=TEAM CONFERENCE^9^105
 ;;^UTILITY(U,$J,358.4,1117,0)
 ;;=INTERACTIVE COMPLEXITY^2^105
 ;;^UTILITY(U,$J,358.4,1118,0)
 ;;=SUBSTANCE ABUSE^8^105
 ;;^UTILITY(U,$J,358.4,1119,0)
 ;;=PSYCHIATRIC DIAGNOSTIC EVALUATION^5^105
 ;;^UTILITY(U,$J,358.4,1120,0)
 ;;=PROLONGED SERVICE^4^105
 ;;^UTILITY(U,$J,358.4,1121,0)
 ;;=TOBACCO CESSATION COUNSELING^10^105
 ;;^UTILITY(U,$J,358.4,1122,0)
 ;;=ADJUSTMENT DISORDERS^2^106
 ;;^UTILITY(U,$J,358.4,1123,0)
 ;;=ANXIETY DISORDERS^4^106
 ;;^UTILITY(U,$J,358.4,1124,0)
 ;;=AMNESTICS^3^106
 ;;^UTILITY(U,$J,358.4,1125,0)
 ;;=ORGANIC DISORDERS^13^106
 ;;^UTILITY(U,$J,358.4,1126,0)
 ;;=DEMENTIA^8^106
 ;;^UTILITY(U,$J,358.4,1127,0)
 ;;=DELIRIUM^7^106
 ;;^UTILITY(U,$J,358.4,1128,0)
 ;;=BIPOLAR DISORDERS^5^106
 ;;^UTILITY(U,$J,358.4,1129,0)
 ;;=PSYCHOSIS/OTHER^17^106
 ;;^UTILITY(U,$J,358.4,1130,0)
 ;;=PERSONALITY DISORDERS^15^106
 ;;^UTILITY(U,$J,358.4,1131,0)
 ;;=SEXUAL DISORDERS^19^106
 ;;^UTILITY(U,$J,358.4,1132,0)
 ;;=SLEEP DISORDERS^20^106
 ;;^UTILITY(U,$J,358.4,1133,0)
 ;;=OTHER DISORDERS^14^106
 ;;^UTILITY(U,$J,358.4,1134,0)
 ;;=SUBSTANCE RELATED DISORDERS^22^106
 ;;^UTILITY(U,$J,358.4,1135,0)
 ;;=V CODES^23^106
 ;;^UTILITY(U,$J,358.4,1136,0)
 ;;=PREVENTION/COUNSELING/SCREEN^16^106
 ;;^UTILITY(U,$J,358.4,1137,0)
 ;;=DEPRESSION^9^106
 ;;^UTILITY(U,$J,358.4,1138,0)
 ;;=MOOD DISORDERS (OTHER)^11^106
 ;;^UTILITY(U,$J,358.4,1139,0)
 ;;=SCHIZOPHRENIA^18^106
 ;;^UTILITY(U,$J,358.4,1140,0)
 ;;=SOMATIFORM DISORDERS^21^106
 ;;^UTILITY(U,$J,358.4,1141,0)
 ;;=EATING DISORDERS^10^106
 ;;^UTILITY(U,$J,358.4,1142,0)
 ;;=NEUROLEPTIC-INDUCED MOVEMENT DISORD^12^106
 ;;^UTILITY(U,$J,358.4,1143,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^1^106
 ;;^UTILITY(U,$J,358.4,1144,0)
 ;;=BRAIN DISORDERS^6^106
 ;;^UTILITY(U,$J,358.4,1145,0)
 ;;=ESTABLISHED PATIENT^1^107
 ;;^UTILITY(U,$J,358.4,1146,0)
 ;;=CONSULTATIONS/OPINIONS^2^107
 ;;^UTILITY(U,$J,358.4,1147,0)
 ;;=NEWPATIENTS^3^107
 ;;^UTILITY(U,$J,358.4,1148,0)
 ;;=CEREBROVASCULAR DIS^2^108
 ;;^UTILITY(U,$J,358.4,1149,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^12^108
 ;;^UTILITY(U,$J,358.4,1150,0)
 ;;=HEADACHE^5^108
 ;;^UTILITY(U,$J,358.4,1151,0)
 ;;=DIZZINESS^3^108
 ;;^UTILITY(U,$J,358.4,1152,0)
 ;;=NEURODEGENERATIVE DIS^8^108
 ;;^UTILITY(U,$J,358.4,1153,0)
 ;;=PAIN^11^108
 ;;^UTILITY(U,$J,358.4,1154,0)
 ;;=NEUROPATHIES^9^108
 ;;^UTILITY(U,$J,358.4,1155,0)
 ;;=ENCEPHALOPATHY^4^108
 ;;^UTILITY(U,$J,358.4,1156,0)
 ;;=SPINAL CONDITIONS^13^108
 ;;^UTILITY(U,$J,358.4,1157,0)
 ;;=VISION DISTURBANCES^15^108
 ;;^UTILITY(U,$J,358.4,1158,0)
 ;;=MOVEMENT DISORDERS^6^108
 ;;^UTILITY(U,$J,358.4,1159,0)
 ;;=OTHER^10^108
 ;;^UTILITY(U,$J,358.4,1160,0)
 ;;=CARDIAC DISORDERS^1^108
 ;;^UTILITY(U,$J,358.4,1161,0)
 ;;=NEOPLASMS^7^108
 ;;^UTILITY(U,$J,358.4,1162,0)
 ;;=SYMPTOMS^14^108
 ;;^UTILITY(U,$J,358.4,1163,0)
 ;;=NEUROLOGY/SEIZURE^7^109
 ;;^UTILITY(U,$J,358.4,1164,0)
 ;;=EEG^4^109
 ;;^UTILITY(U,$J,358.4,1165,0)
 ;;=SLEEP TESTING^9^109
 ;;^UTILITY(U,$J,358.4,1166,0)
 ;;=MUSCLE TESTING/EMG^6^109
 ;;^UTILITY(U,$J,358.4,1167,0)
 ;;=EVOKED POTENTIAL^5^109
 ;;^UTILITY(U,$J,358.4,1168,0)
 ;;=BIOPSY^2^109
 ;;^UTILITY(U,$J,358.4,1169,0)
 ;;=AUTONOMIC FUNCTION TESTS^1^109
 ;;^UTILITY(U,$J,358.4,1170,0)
 ;;=STEREOTACTIC^10^109
 ;;^UTILITY(U,$J,358.4,1171,0)
 ;;=EDUCATION^3^109
